| Literature DB >> 31287617 |
Khaled A Selim1, Tatyana Lapina2, Karl Forchhammer1, Elena Ermilova2.
Abstract
During evolution, several algae and plants bEntities:
Keywords: N-acetyl-l-glutamate kinase; Nonphotosynthetic plastids; PII-signalling; TCA/GS-GOGAT cycles; algal metabolomics; arginine biosynthesis
Year: 2019 PMID: 31287617 PMCID: PMC7027753 DOI: 10.1111/febs.14989
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542
Figure 1Central C‐ and N‐ metabolism in nonphotosynthetic alga Polytomella parva and in photosynthetic alga Chlamydomonas reinhardtii. (A) Inferred metabolic pathways in non‐ and photosynthetic algae P. parva and C. reinhardtii, respectively, with special reference to the TCA‐ and GS/GOGAT‐cycles. The scheme of metabolic pathway is compartmentalized in terms of mitochondrion, plastid and cytosol, according to 21. Polytomella parva uses ethanol as a carbon source for, while C. reinhardtii fixes CO 2 or/and uses acetate as external carbon. (B) Growth of P. parva (inset; scale 10 μm) under N‐limited and N‐rich conditions. The arrow at the right end shows the time point (45 h) of harvesting P. parva for metabolite analysis. The experiment was started with an exponentially growing culture of P. parva under nitrogen‐rich conditions, which was collected and shifted to N‐limiting (0.375‐mm NH 4 +) conditions or back again to the N‐rich conditions (7.5‐mm NH 4 +) (arrow left). Significant metabolic alterations of (C) PEP (C‐metabolism), (D) TCA‐cycle intermediates and (E) the major amino acids of N‐assimilation reactions and GS/GOGAT‐cycle intermediates within the nonphotosynthetic algae P. parva cells after shift from rich‐ to low‐nitrogen conditions in comparison to the photosynthetic algae C. reinhardtii under rich nitrogen (7.5‐mm NH 4 +) condition. The metabolite concentrations are relative to P. parva cells under high‐nitrogen supply (normalized to 1.0, red bars) for three independent replicates, and the standard deviation (SD) is indicated by error bars.
Figure 2Multiple amino acid sequence alignment of PII proteins. The protein sequences were derived from NCBI database. The sequences are derived from PII polypeptides of the nonphotosynthetic alga Polytomella parva (Polyt), green photosynthetic alga Chlamydomonas reinhardtii (Cr; XP_001703658.1), land plants Physcomitrella patens (Physco; BAF36548.1), Arabidopsis thaliana (At; NP_192099.1), Oryza sativa Japonica (Os; Os05g0133100) and Solanum lycopersicum (Sl; AAR14689.1), red algae Porphyra purpurea (Pp; NP_053864.1), Porphyra umbilicalis (Pu; AFC39923.1) and Pyropia yezoensis (Py; AGH27579.1), cyanobacteria Synechococcus elongatus PCC 7942 (Sy; P0A3F4.1), Synechocystis sp. PCC 6803 (Sc; CAA66127.1) and Escherichia coli (Ec; CAQ32926.1). All the indicated regions and residues have been characterized in previous work 17, 24, 25, 26, 27. The regions referring to T‐, B‐, C‐ and Q‐loops are indicated 17. Highlighted residues in black are invariant in at least 55% of aligned PIIs proteins. Amino acids in blue represent similar residues. Boxs I and II indicate PII signature patterns. The positions of known PIIs post‐translational modification sites: the phosphorylation site in cyanobacterial S. elongatus PII (S49) and the uridylation site in E. coli PII (Y51) are indicated by solid black and white arrows, respectively. The amino acid residues involved in binding of ATP (●), NAGK (■) and 2‐OG (▲) are indicated 24, 25, 26, 27. The alignment was done using the ClustalW program and manually refined.
Figure 3Multiple amino acid sequence alignment of NAGK proteins. The NAGK protein sequences were derived from UniProt database. The sequences are derived from NAGK polypeptides from nonphotosynthetic alga Polytomella parva (A6XGV3), green photosynthetic alga Chlamydomonas reinhardtii (A8HPI1) and Chlorella variabilis (E1ZQ49), land plants Physcomitrella patens (A0JC02) and Arabidopsis thaliana (Q9SCL7), red algae Porphyra purpurea (P69365), cyanobacteria Synechococcus elongatus PCC 7942 (Q6V1L5) and Synechocystis sp. PCC 6803 (P73326), and bacteria Thermotoga maritima (Q9X2A4) and Escherichia coli (P0A6C8). Highlighted residues in black are invariant in at least 55% of aligned NAGK proteins. Amino acids in blue represent similar residues. Box I refers to plastid‐targeting signal peptides sequence (ChloP server). Box II indicates an N‐terminal signature extension of Arg‐sensitive NAGK proteins, which is absent in Arg‐insensitive E. coli NAGK 28. In Box II, the previously identified signature sequence of Arg‐sensitive NAGK from Thermotoga maritima is highlighted in yellow, which is involved in forming the allosteric Arg binding site 28. Amino acid residues directly involved in allosteric Arg binding are highlighted in red and are deduced from known structures of NAGK: Arg complexes from Thermotoga maritima NAGK (PDB: http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2BTY) 28 and Arabidopsis thaliana (PDB: http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2RD5) 26. The alignment was done using the ClustalW program and manually refined.
Figure 4Characterization of PIIs modulated NAGK activity. (A) Catalytic activity of Ppa NAGK in presence or absence of Ppa PII and of 5‐mm Gln, as indicated. NAG was used as a variable substrate, as indicated. (B–F) Arginine feedback inhibition of NAGK enzymes in presence or absence of PII proteins, with or without 5‐mm glutamine, as indicated. (B) Ppa NAGK with Ppa PII; (C) Cr NAGK with Ppa PII; (D) Cr NAGK with Cr PII; (E) Ppa NAGK with Cr PII and (F) Ppa NAGK with Os PII. The Arg‐IC 50 in (D) for free Cr NAGK (0.27 ± 0.02 mm), Cr PII‐Cr NAGK in absence of Gln (0.25 ± 0.01) and Cr PII‐Cr NAGK in presence of Gln (0.82 ± 0.09 mm) were comparable to the previously published data 17. All data were fitted using GraphPad prism program. The arginine feedback inhibition data were fitted according to a sigmoidal dose‐response curve, yielding an IC 50 for arginine. SD as indicated by error bars, represents independent triplicate measurements.
Figure 5Effect of glutamine and 2‐OG on PII‐mediated NAGKs activation. (A) Glutamine‐dependent activation of arginine‐inhibited Ppa NAGK or arginine‐inhibited Cr NAGK by Ppa PII, as indicated. (B) Effect of 2‐OG on Ppa PII and Cr PII proteins in the presence of 5‐mm glutamine on activation of arginine‐inhibited Ppa NAGK, as indicated. The assays were performed in presence of 0.5‐mm arginine for Ppa NAGK or 0.12‐mm arginine for Cr NAGK. Data were fitted using a graphpad prism, yielding an EC 50 for Gln and an IC 50 for 2‐OG. SD as indicated by error bars, represents triplicate independent measurements.
Figure 6Complex formation of Ppa PII‐NAGKs analysed by SEC‐MALS. Gel filtration of PII‐NAGK complexes was carried out as described in Methods. SEC‐MALS profiles for (A) Ppa NAGK in presence or absence of Ppa PII and 5‐mm glutamine and (B) Cr NAGK in presence or absence of Ppa PII or of Cr PII with or without glutamine, as indicated. The mass of the eluted particles was determined via MALS and plotted on the right y‐axis. The protein elution profile was monitored using UV signal at 280 nm and plotted on the y‐left. (C and D) The eluted protein fractions between 12.5 to 17.5 mL corresponding to Ppa PII‐Ppa NAGK complexes as shown in (A) or for Ppa PII‐Cr NAGK complexes as shown in (B) were collected and subjected to Glycine‐SDS/PAGE, and revealed the presence of Ppa PII and NAGK proteins after Coomassie blue stain.
Figure 7Surface plasmon resonance spectroscopy analysis of PII‐NAGK complex formation. Cr PII or Ppa PII were injected to FC2‐immobilized Cr NAGK or Ppa NAGK. (A) Strict Mg2+‐ATP/Gln dependency of 1000‐nm Cr PII binding to Cr NAGK. (B–F) Binding of 1000‐nm Ppa PII to various NAGK enzymes under various conditions. (B): Binding of Ppa PII to Ppa NAGK, as indicated. (C) Stability of the Ppa PII‐Ppa NAGK complex formed by injection of 100‐, 200‐ or 1000‐nm Ppa PII, as indicated, in absence of any effector molecules during SPR dissociation. The arrows indicate the injection of 2‐mm ADP, which did not affect complex stability/dissociation. (D) Dissociation of Ppa PII‐Ppa NAGK complex; shows the average of the response signals shown in (C) in form of % at t:430s and at t:760s (330s and 660s after the end of the injection, respectively). The signals at t:110s (10s after the end of the injection) were normalized to 100%. SD as indicated by error bars, represents triplicate independent measurements. (E) Binding of 1000‐nm Ppa PII to Cr NAGK, as indicated. (F) K d value for binding Ppa PII to NAGK calculated from ∆RU at t:100s. The inset in (F) shows the Ppa PII titration (from 50 to 1000 nm) to NAGK in absence of effectors molecules, as indicated.
Figure 8Ability of Ppa NAGK to bind Cr PII or Os PII in effector molecule‐independent manner. Interaction between Ppa NAGK and Cr PII or Os PII was analysed by SPR; 1000 nm of Cr PII or Os PII were injected to FC2‐immobilized Ppa NAGK. (A and B) Binding of Cr PII to Ppa NAGK, as indicated. (C) 2‐OG independent binding of Cr PII to Ppa NAGK, as indicated. (D) Binding of Os PII to Ppa NAGK, as indicated; shows no negative influence of ADP or 2‐OG on Os PII‐Ppa NAGK complex.